| ²é¿´: 1082 | »Ø¸´: 1 | ||
[ÇóÖú]
ÇëÎÊ£¬ÓÐÖªµÀ±»FDAÅú×¼µÄ¿ÉÒÔÓÃÓڷβ¿¸øÒ©µÄ±íÃæ»îÐÔ¼ÁµÄÂ𣿠ÒÑÓÐ1È˲ÎÓë
|
| ÐèÒªÕâ·½ÃæµÄÐÅÏ¢£¬µ«ÊDz»ÖªµÀÔÚÄIJéÕÒ£¬Ï£ÍûÖªµÀµÄͬ°û¿ÉÒÔÖ¸µ¼Ò»Ï£¬Íò·Ö¸Ðл£¡ |
» ²ÂÄãϲ»¶
319Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ
ÒѾÓÐ15È˻ظ´
085600£¬320·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
085600µ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á£º085600²ÄÁÏÓ뻯¹¤£¬¿¼²Ä¿Æ»ù£¬×Ü·Ö319
ÒѾÓÐ26È˻ظ´
0703»¯Ñ§
ÒѾÓÐ5È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬320·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ÄÏÅ©090401£¬268£¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
323Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
voyager88
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 584 (²©Ê¿)
- ½ð±Ò: 2387
- É¢½ð: 4182
- ºì»¨: 338
- Ìû×Ó: 1994
- ÔÚÏß: 551.7Сʱ
- ³æºÅ: 1259270
- ×¢²á: 2011-04-08
- רҵ: Ò©¼Áѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ãβ»Âädyn: ½ð±Ò+5, ¡ïÓаïÖú 2015-09-08 12:49:01
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ãβ»Âädyn: ½ð±Ò+5, ¡ïÓаïÖú 2015-09-08 12:49:01
|
Á×Ö¬£¬ÓÍËá¶¼¿ÉÒÔʹÓã¬Ïê¼ûÎüÈë·Û¼Á£¬ÆøÎí¼ÁÐÐÒµÖ¸ÄÏ¡£µ«ÊǼ¶±ðÒªÇó½Ï¸ß£¬²»ÊÇÒ»°ãµÄÁ×Ö¬¡£ÒÔÏÂÊÇÖ¸µ¼ÔÔòÔÎÄ£¬ÒëÎͼ¸øÄ㸽ÉÏÁË£¬ÏëÒªÕÒµ½ÔÎļþ£¬¸´ÖÆÆäÖÐÒ»¾ä»°£¬°Ù¶È¾ÍÄܸ㶨 When Lecithin, NF, a surfactant, is used in MDI formulations, additional acceptance criteria and tests controlling the complete compositional profile should be used (e.g., levels of phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl inositol, lysophosphatidyl choline, phosphatidic acid, triglycerides, fatty acids, carbohydrates). NFÖÐÁ×Ö¬ÊÇÒ»ÖÖ±íÃæ»îÐÔ¼Á£¬µ±ÓÃÓÚMDIsʱ£¬Ó¦Ê¹Óøü¶àµÄÑéÊÕ±ê×¼ºÍ²âÊÔÏîÄ¿£¬ÒÔ¿ØÖÆ×é·ÖÍêÕûµÄÌØÕ÷£¨Á×Ö¬õ£µ¨¼î¡¢Á×Ö¬õ£´¼°·¡¢Á×Ö¬õ£¼¡´¼¡¢ÈÜѪÁ×Ö¬õ£µ¨¼î¡¢Á×Ö¬Ëá¡¢¸ÊÓÍÈýõ¥¡¢Ö¬·¾ËáºÍ̼ˮ»¯ºÏÎïµÈµÄˮƽ£©¡£ When Oleic Acid, NF is used as a surfactant in MDI formulations, additional specifications should be included for identification, assay, and for characterization and control of the compositional profile of impurities (e.g., individual specified fatty acids, unknowns). NFÖÐÓÍËáÓÃ×÷Ò»ÖÖ±íÃæ»îÐÔ¼Á£¬µ±ÓÃÓÚMDIsʱ£¬Ó¦½¨Á¢½øÒ»²½¼ø¶¨¡¢º¬Á¿¡¢±íÕ÷ºÍ¿ØÖÆÔÓÖÊÆ×µÈµÄÖÊÁ¿±ê×¼£¨ÈçÓÎÀëºÍÌØÊâÖ¬·¾Ëᣬδ֪Î¡£ |

2Â¥2015-09-08 11:13:06














»Ø¸´´ËÂ¥